Stay updated on Immunotherapy for Anal Canal Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy for Anal Canal Cancer Clinical Trial page.

Latest updates to the Immunotherapy for Anal Canal Cancer Clinical Trial page
- CheckyesterdayChange DetectedTwo new study centers were added (University of Michigan Rogel Cancer Center and VCU Massey Comprehensive Cancer Center) while two centers were removed, imaging service terms were updated to Diagnostic CAT Scan Service Type and Diagnostic CAT Scan, and the study's revision was updated from v3.5.3 to v3.5.4.SummaryDifference0.6%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now shows the trial’s updated results status and reporting timeline, including a new “Results Posted” date (2026-04-22) and updated results reporting entries. It also adds/updates the defined outcome measures and their accompanying methodology text for efficacy (ORR, PFS, OS), safety (treatment-related toxicities graded by CTCAE v5.0), and exploratory biomarker analyses.SummaryDifference2%

- Check29 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check58 days agoChange DetectedVersion bump from v3.4.3 to v3.5.0; no changes to study details or patient-facing information.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check79 days agoChange DetectedAdded a new publication citation for NCI9673 Part B (J Clin Oncol 2026; 44(6):497-507) to Publications.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy for Anal Canal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy for Anal Canal Cancer Clinical Trial page.